«Medicines for reduced ejection fraction heart failure in Central region of Portugal’s primary care: a 2022 observational study» (2024) Revista Portuguesa de Medicina Geral e Familiar, 40(4), pp. 339–46. doi:10.32385/rpmgf.v40i4.13770.